产品编号：D528813
产品规格：10mg
产品价格：面议
| 标准品编号: | D528813 |
| 名称: | Dolutegravir O-β-D-Glucuronide-O-Triacetate Methyl Ester |
| 别名: | (2S,3R,4S,5S,6S)-2-(((4R,12aS)-9-((2,4-Difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-yl)oxy)-6-(methoxycarbonyl)tetrahydro-2H-pyran-3,4,5-triyl Triacetate |
| 分子式: | C₃₃H₃₅F₂N₃O₁₄ |
| 外观: | Off 白色固体 |
| 分子量: | 735.64 |
| 溶解度: | Dichloromethane, Methanol |
| 种类: | Standards; Chiral Molecules; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | Dolutegravir O-β-D-Glucuronide-O-Triacetate Methyl Ester is an intermediate in synthesizing Dolutegravir O-β-D-Glucuronide (D528810), a metabolite of Dolutegravir (D528800); a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has been shown to potently inhibit HIV replication in cells such as peripheral blood mononuclear cells (PBMCs), MT-4 cells and CIP4 cells infected with a self-inactivating PHIV lentiviral vector. |
| 参考文献 | |
